genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
The Italian Job: An Interview with Gene Therapist Federico Mingozzi
Coronavirus
A ‘Patch’-Work Solution to Vaccine Delivery
Bioinformatics
NVIDIA Powers Up in Drug Discovery
Coronavirus
Life Sciences Go Viral in Maryland
Coronavirus
One COVID-19 Shot, Two Approaches
News
Synthetic Biology
Minimal CRISPR-Cas3 System Makes Substantial Deletions
Biomarkers
Diagnostic for Detecting Alzheimer’s Earlier Developed
Cancer
How Melanoma Increases Immunotherapy Resistance
OMICs
Role of Gut Microbiome in Multiple Sclerosis Depends on Genetic Makeup
Genetics
Got to Go? Scientists Uncover Gene That Helps Sense a Full…
Insights
All
Trends for 2020
Bioprocessing
Digital Pharma Is a Major Cultural Change
Bioprocessing
Contract Manufacturer Sets Up for Fill-and-Finish Next-Generation Therapies
Gene Therapy
The Italian Job: An Interview with Gene Therapist Federico Mingozzi
Bioprocessing
Ori Biotech Raises $30 Million in Financing
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Synthetic Biology
Minimal CRISPR-Cas3 System Makes Substantial Deletions
Biomarkers
Diagnostic for Detecting Alzheimer’s Earlier Developed
Bioprocessing
Digital Pharma Is a Major Cultural Change
Bioprocessing
Counting Growth in Continuous Biomanufacturing Operations
Magazine
October 2020 Vol. 40 No. 10
Spatial: The Next Omics Frontier
October 2020 Vol. 40 No. 10
Gene Therapy Startups Extend Biotech’s Legacy
October 2020 Vol. 40 No. 10
Viral or Nonviral: Which Is Better for CRISPR-Based Therapies?
October 2020 Vol. 40 No. 10
The Chronicles of CRISPR
October 2020 Vol. 40 No. 10
Host Cell Protein Analysis Informs Risk Assessment
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Neurological Disorders
ALS
ALS
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Sponsored
Working with ALS Mice: Guidelines for Preclinical Testing and Colony Management
ALS
Neurodegenerative Treatments Build to a Tipping Point
ALS
Is ALS More Genetically Driven than Once Thought?
ALS
Sanofi, Denali Launch $1B+ Alliance to Develop RIPK1 Inhibitors for Neurological, Inflammatory Diseases
ALS
Amyloids Shown to Also Play Beneficial Role in Developing Healthy Muscle Tissue
ALS
Axovant Licenses Benitec Gene Therapy Candidates for OPMD, Neurological Disorders
ALS
Flex Pharma Axes 60% of Workforce, Explores Sale after Halting Phase...
ALS
Neuraltus Weighs Future of Lead Candidate NP001 after Failure in Phase...
ALS
Biogen, Ionis Launch $1B+ Expanded Neuro Drug Partnership, following Spinraza Success
ALS
Novel Research Model Offers Hope to ALS and MS Patients
ALS
Hardening of the RNA Condensates May Solidify Neurodegeneration
ALS
Hope for ALS Patients Comes from New Understanding of RNA Metabolism...
ALS
CRISPR Screen Identifies Genetic Modifiers of ALS
ALS
CRISPR Human Knockout Screens Identify New Target for ALS
ALS
Studying Changing Neuron Size May Lead to New Therapies for Motor...
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Flex Pharma cites unspecified “oral tolerability concerns” in halting Phase II trials of FLX-787 in amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth (CMT). [© whitehoune / Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/170123090806_1_900x6009916143062-324x160.jpg "Flex Pharma Axes 60% of Workforce, Explores Sale after Halting Phase II Trials in ALS, CMT")
![The hnRNP A1B is expressed in the central nervous system and forms cytoplasmic aggregates in ALS patient neurons. [CRCHUM]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar19_2018_CRCHUM_hnRNPA1B2262381965-324x160.jpg "Hope for ALS Patients Comes from New Understanding of RNA Metabolism Misregulation")
